ABX-CRO is proud to announce the friendly acquisition of ClinSmart LLC (Pennsylvania, USA), a well-established clinical quality CRO. This transaction represents a major milestone in ABX-CRO’s continued growth and the expansion of its global service portfolio.
Building on a long-standing and trusted partnership, the integration of ClinSmart significantly strengthens ABX-CRO’s expertise in clinical quality and global trial execution. Together, we now offer a unique, highly specialised service portfolio for nuclear medicine and theranostics, seamlessly integrating clinical and imaging services across the US, EU, India, and beyond.
We warmly welcome the ClinSmart team to ABX-CRO. This achievement marks the beginning of an exciting new chapter and further enhances our ability to support the successful development and market access of innovative therapies worldwide.